A new study led by researchers at the American Museum of Natural History presents the oldest known example in the fossil record of an evolutionary arms race.
Pembrolizumab is under clinical development by Merck and currently in Phase II for Metastatic Breast Cancer. According to GlobalData, Phase II drugs for Metastatic Breast Cancer have a 32% phase ...
Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...